Columbia Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-821
| Closed | -$111K | – | 221 |
|
|
2019
Q1 | $111K | Buy |
+821
| New | +$111K | 0.03% | 210 |
|
|
2018
Q4 | – | Sell |
-995
| Closed | -$138K | – | 226 |
|
|
2018
Q3 | $138K | Buy |
+995
| New | +$138K | 0.04% | 200 |
|
|
2017
Q1 | – | Sell |
-1,780
| Closed | -$218K | – | 217 |
|
|
2016
Q4 | $218K | Hold |
1,780
| – | – | 0.07% | 165 |
|
|
2016
Q3 | $218K | Hold |
1,780
| – | – | 0.08% | 169 |
|
|
2016
Q2 | $208K | Sell |
1,780
-750
| -30% | -$87.6K | 0.07% | 163 |
|
|
2016
Q1 | $352K | Hold |
2,530
| – | – | 0.13% | 132 |
|
|
2015
Q4 | $482K | Hold |
2,530
| – | – | 0.19% | 107 |
|
|
2015
Q3 | $396K | Hold |
2,530
| – | – | 0.16% | 124 |
|
|
2015
Q2 | $457K | Sell |
2,530
-400
| -14% | -$72.3K | 0.17% | 121 |
|
|
2015
Q1 | $508K | Hold |
2,930
| – | – | 0.19% | 123 |
|
|
2014
Q4 | $542K | Hold |
2,930
| – | – | 0.21% | 116 |
|
|
2014
Q3 | $486K | Sell |
2,930
-500
| -15% | -$82.9K | 0.2% | 111 |
|
|
2014
Q2 | $536K | Hold |
3,430
| – | – | 0.22% | 108 |
|
|
2014
Q1 | $522K | Sell |
3,430
-300
| -8% | -$45.7K | 0.23% | 100 |
|
|
2013
Q4 | $496K | Buy |
+3,730
| New | +$496K | 0.22% | 103 |
|